Trabectedin for recurrent WHO grade 2 or 3 meningioma: a randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG) - Preusser, Matthias; Silvani, Antonio; Le Rhun, Emilie; Soffietti, Riccardo; Lombardi, Giuseppe; Sepulveda, Juan Manuel; Brandal, Petter; Brazil, Lucy; Bonneville-Levard, Alice; Lorgis, Veronique; Vauleon, Elodie; Bromberg, Jacoline; et al. (Neuro-Oncology, 2022)